Molecular Imaging LitBriefs - April 2012
(177)Lu-DO3A-HSA-Z (EGFR:1907): characterization as a potential radiopharmaceutical for radionuclide therapy of EGFR-expressing head and neck carcinomas.
http://www.ncbi.nlm.nih.gov/pubmed/22418921
Hoppmann S, Qi S, Miao Z, Liu H, Jiang H, Cutler CS, Bao A, Cheng Z.
J Biol Inorg Chem. 2012 Mar 16. [Epub ahead of print]
Contrast Ultrasound Imaging for Identification of Early Responder Tumor Models to Anti-Angiogenic Therapy.
http://www.ncbi.nlm.nih.gov/pubmed/22425376
Sirsi SR, Flexman ML, Vlachos F, Huang J, Hernandez SL, Kim HK, Johung TB, Gander JW, Reichstein AR, Lampl BS, Wang A, Hielscher AH, Kandel JJ, Yamashiro DJ, Borden MA.
Ultrasound Med Biol. 2012 Mar 16. [Epub ahead of print]
Dendrimer-entrapped gold nanoparticles as potential CT contrast agents for blood pool imaging.
http://www.ncbi.nlm.nih.gov/pubmed/22429280
Wang H, Zheng L, Guo R, Peng C, Shen M, Shi X, Zhang G.
Nanoscale Res Lett. 2012 Mar 19;7(1):190. [Epub ahead of print]
Development of (177) Lu-nanobodies for radioimmunotherapy of HER2-positive breast cancer: evaluation of different bifunctional chelators.
http://www.ncbi.nlm.nih.gov/pubmed/22434639
D'Huyvetter M, Aerts A, Xavier C, Vaneycken I, Devoogdt N, Gijs M, Impens N, Baatout S, Ponsard B, Muyldermans S, Caveliers V, Lahoutte T.
Contrast Media Mol Imaging. 2012 Mar;7(2):254-64.
An Early Investigation of Ytterbium Nanocolloids for Selective and Quantitative "Multicolor" Spectral CT Imaging.
http://www.ncbi.nlm.nih.gov/pubmed/22385324
Pan D, Schirra CO, Senpan A, Schmieder AH, Stacy AJ, Roessl E, Thran A, Wickline SA, Proska R, Lanza GM.
ACS Nano. 2012 Mar 8. [Epub ahead of print]
Evaluation of the angiogenesis inhibitor KR-31831 in SKOV-3 tumor-bearing mice using (64)Cu-DOTA-VEGF(121) and microPET.
http://www.ncbi.nlm.nih.gov/pubmed/22406249
Lee I, Yoon KY, Kang CM, Lin X, Chen X, Kim JY, Kim SM, Ryu EK, Choe YS.
Nucl Med Biol. 2012 Mar 9. [Epub ahead of print]
Focal breast uptake of 99mTc-sestamibi in a man with spindle cell lipoma.
http://www.ncbi.nlm.nih.gov/pubmed/22415820
Malek H, Ghaedian T, Yaghoobi N, Rastgou F, Bitarafan-Rajabi A, Firoozabadi H.
J Nucl Cardiol. 2012 Mar 14. [Epub ahead of print]
In Vivo pH Imaging with (99m)Tc-pHLIP.
http://www.ncbi.nlm.nih.gov/pubmed/22371188
Macholl S, Morrison MS, Iveson P, Arbo BE, Andreev OA, Reshetnyak YK, Engelman DM, Johannesen E.
Mol Imaging Biol. 2012 Feb 28. [Epub ahead of print]
Long-term multimodal imaging of tumor draining sentinel lymph nodes using mesoporous silica-based nanoprobes.
http://www.ncbi.nlm.nih.gov/pubmed/22425023
Huang X, Zhang F, Lee S, Swierczewska M, Kiesewetter DO, Lang L, Zhang G, Zhu L, Gao H, Choi HS, Niu G, Chen X.
Biomaterials. 2012 Mar 15. [Epub ahead of print]
Molecular Approaches to the Treatment, Prophylaxis, and Diagnosis of Alzheimer's Disease:Novel PET/SPECT Imaging Probes for Diagnosis of Alzheimer's Disease.
http://www.ncbi.nlm.nih.gov/pubmed/22382657
Ono M, Saji H.
J Pharmacol Sci. 2012 Mar 2. [Epub ahead of print]
Molecular imaging of brain tumors with 18F-DOPA PET and PET/CT.
http://www.ncbi.nlm.nih.gov/pubmed/22395034
Calabria F, Chiaravalloti A, Di Pietro B, Grasso C, Schillaci O.
Nucl Med Commun. 2012 Mar 2. [Epub ahead of print]
Molecular imaging of cell death in an experimental model of Parkinson's disease with a novel apoptosis-targeting Peptide.
http://www.ncbi.nlm.nih.gov/pubmed/21567253
Lee MJ, Wang K, Kim IS, Lee BH, Han HS.
Mol Imaging Biol. 2012 Apr;14(2):147-55.
Molecular imaging of cytochrome P450 activity in mice.
http://www.ncbi.nlm.nih.gov/pubmed/22391453
Roncoroni C, Rizzi N, Brunialti E, Cali JJ, Klaubert DH, Maggi A, Ciana P.
Pharmacol Res. 2012 Feb 25. [Epub ahead of print]
MR and optical imaging of early micrometastases in lymph nodes: triple labeling with nano-sized agents yielding distinct signals.
http://www.ncbi.nlm.nih.gov/pubmed/22434638
Kosaka N, Bernardo M, Mitsunaga M, Choyke PL, Kobayashi H.
Contrast Media Mol Imaging. 2012 Mar;7(2):247-53.
Parametric imaging with Bayesian priors: A validation study with (11)C-Altropane PET.
http://www.ncbi.nlm.nih.gov/pubmed/22425668
Dean Fang YH, El Fakhri G, Becker JA, Alpert NM.
Neuroimage. 2012 Mar 9. [Epub ahead of print]
pH as a biomarker of neurodegeneration in Huntington's disease: a translational rodent-human MRS study.
http://www.ncbi.nlm.nih.gov/pubmed/22373643
Chaumeil MM, Valette J, Baligand C, Brouillet E, Hantraye P, Bloch G, Gaura V, Rialland A, Krystkowiak P, Verny C, Damier P, Remy P, Bachoud-Levi AC, Carlier P, Lebon V.
J Cereb Blood Flow Metab. 2012 Feb 29. doi: 10.1038/jcbfm.2012.15. [Epub ahead of print]
A radiolabeled nonapeptide probe targeting PC-3 cells and bone metastases of prostate cancer in mice.
http://www.ncbi.nlm.nih.gov/pubmed/22434635
Qinghua W, Jianli X, Lu L, Zexuan Y, Guansheng T, Hailin G, Jianwei J.
Contrast Media Mol Imaging. 2012 Mar;7(2):223-30.
SHG nanoprobes: Advancing harmonic imaging in biology.
http://www.ncbi.nlm.nih.gov/pubmed/22392481
Dempsey WP, Fraser SE, Pantazis P.
Bioessays. 2012 Mar 6. doi: 10.1002/bies.201100106. [Epub ahead of print]
Single reporter for targeted multimodal in vivo imaging.
http://www.ncbi.nlm.nih.gov/pubmed/22397453
Niers JM, Chen JW, Lewandrowski G, Kerami M, Garanger E, Wojtkiewicz G, Waterman P, Keliher E, Weissleder R, Tannous BA.
J Am Chem Soc. 2012 Mar 21;134(11):5149-56. Epub 2012 Mar 7.
Topical Application of Activity-based Probes for Visualization of Brain Tumor Tissue.
http://www.ncbi.nlm.nih.gov/pubmed/22427947
Cutter JL, Cohen NT, Wang J, Sloan AE, Cohen AR, Panneerselvam A, Schluchter M, Blum G, Bogyo M, Basilion JP.
PLoS One. 2012;7(3):e33060. Epub 2012 Mar 13.
Value of PET/CT and MR Lymphography in Treatment of Prostate Cancer Patients with Lymph Node Metastases.
http://www.ncbi.nlm.nih.gov/pubmed/22417806
Fortuin AS, Deserno WM, Meijer HJ, Jager GJ, Takahashi S, Debats OA, Reske SN, Schick C, Krause BJ, van Oort I, Witjes AJ, Hoogeveen YL, Th van Lin EN, Barentsz JO.
Int J Radiat Oncol Biol Phys. 2012 Mar 13. [Epub ahead of print]